Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL) is a member of the ankyrin repeat domain-containing protein family, characterized by the presence of ankyrin repeats, which are known protein–protein interaction motifs[1][3]. ANKRD30BL is expressed in various human tissues, but its precise molecular function remains undetermined. Studies have indicated that the ANKRD30BL transcript is significantly enriched in tissues affected by chronic periodontitis, suggesting involvement in inflammatory and potentially oncogenic processes, possibly through pathways that govern cell cycle progression, apoptosis, or responses to cellular stress[1][3]. Because of the broad roles of ankyrin repeat domains in mediating interactions and regulatory processes, ANKRD30BL may act as a regulator or adaptor within certain signaling pathways, but experimental confirmation is needed. Currently, no evidence specifically designates ANKRD30BL as a therapeutic target, nor are there known drugs that interact with it or established uses in biomarker or safety contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 30B-like (ANKRD30BL).